OptiScan Biomedical Lands $29,471,095 New Funding Round

  • Feed Type
  • Date
    6/8/2016
  • Company Name
    OptiScan Biomedical
  • Mailing Address
    24590 Clawiter Road Hayward, CA 94545 USA
  • Company Description
    OptiScan Biomedical Corporation has developed an innovative monitoring platform for use in hospital intensive care units (ICU) to support clinicians in detecting changes more rapidly in critically ill patients, enabling more timely intervention. The OptiScanner platform is presently focused on delivering automated bedside glucose monitoring to support clinicians’ reach and maintain the right level of glucose control.
  • Website
    http://www.optiscancorp.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $29,471,095
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 16 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy